New Treatment Approved for Lung Cancer
KRAS mutations were once thought to be resistant to drug therapy.
Home > Patients, Caregivers, and Advocates > Research > New Treatment Approved for Lung Cancer
KRAS mutations were once thought to be resistant to drug therapy.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now